Effective treatment of Clostridium difficile infections demands a shift away from antibiotics towards toxin-neutralizing agents. Work by Bender et al., using a drug that attenuates toxin action in vivo without affecting bacterial survival, demonstrates the exciting potential of small molecules as a new modality in the fight against C. difficile.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.tim.2015.10.009 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!